0001225208-11-012073.txt : 20110421 0001225208-11-012073.hdr.sgml : 20110421 20110421104015 ACCESSION NUMBER: 0001225208-11-012073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110420 FILED AS OF DATE: 20110421 DATE AS OF CHANGE: 20110421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bateson Susan D. CENTRAL INDEX KEY: 0001191234 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 11772386 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER NAME: FORMER CONFORMED NAME: MCKAY SUSAN D BATESON DATE OF NAME CHANGE: 20020920 4 1 doc4.xml X0303 4 2011-04-20 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001191234 Bateson Susan D. 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 1 Senior Vice President Common Stock 2011-04-20 4 M 0 24000.0000 0.5200 A 89270.0000 D Common Stock 2011-04-20 4 S 0 24000.0000 28.7499 D 65270.0000 D Employee Stock Option - Right to Buy 0.5200 2011-04-20 4 M 0 24000.0000 0.0000 D 2019-03-10 Common Stock 24000.0000 67997.0000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 3/18/11. This transaction was executed in multiple trades at prices ranging from $28.09 to $28.94. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available. One eighth of the options granted vested on September 10, 2009, the six-month anniversary date of the grant, and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2009. /s/ Susan D. Bateson 2011-04-21